Home Medicine Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
Article
Licensed
Unlicensed Requires Authentication

Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications

  • ORCID logo , , ORCID logo , , ORCID logo , , , ORCID logo and ORCID logo EMAIL logo
Published/Copyright: July 24, 2025

Abstract

Objectives

The UK National Institute for Health and Care Excellence has recommended thresholds for total vitamin B12 (B12) assays with interchangeable results for identifying B12 deficiency. We assessed the agreement between B12 methods, to evaluate whether the thresholds may be assumed applicable to all assays.

Methods

A total of 19 External Quality Assessment (EQA) exercises (1,791 determinations) based on human subjects-pool materials and 97 serum samples were retrieved to characterize the agreement between Alinity and Architect (Abbott Diagnostics), Access DXi (Beckman Coulter Diagnostics), Atellica and ADVIA Centaur (Siemens Healthcare Solution) compared to Cobas (Roche Diagnostics), considered as comparator because its calibrator traceability to the World Health Organisation (WHO) International Standard (IS) code 03/178. Ordinary least squares and Bland-Altman were used for this purpose.

Results

Abbott and Beckman methods overestimated and underestimated, respectively, B12 concentrations vs. Roche and the other methods. We reported similar systematic or proportional error patterns between EQA and serum samples. Only Beckman was affected by both errors. Due to the wide Limit of Agreement Interval, we cannot confidently conclude on the agreement between Roche and the other methods. However, the inter-method bias was well lower than the desirable goal of 9.4 % for Abbott Architect and also lower for Siemens ADVIA Centaur.

Conclusions

The recommended thresholds for serum total B12 should not be assumed applicable to all assays, due to the poor agreement among the currently available methods, a limitation that persists despite the release of the WHO IS 03/178.


Corresponding author: Simona Ferraro, Center of Functional Genomics and Rare diseases, Department of Pediatrics, Buzzi Children’s Hospital, Milan, Italy, E-mail:

Acknowledgments

The authors thank Fabio Pasotti, Duilio Brugnoni working on B12 EQA program of the Italian Regional Coordination Center for Laboratory Medicine (Lombardy).

  1. Research ethics: The study was approved by the National Research Ethics Committee (Ref 11/H/1302/5).

  2. Informed consent: Not applicable.

  3. Author contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. S. Ferraro, conceptualization (lead) and writing original draft (equal); B.M. Cesana formal analysis (lead) and writing original draft (equal); S. daMolin, resources (equal); S. Buoro, resources (lead); N Jassam resources (equal); JH Barth resources (equal); S. Marcovina: reviewing and editing (lead); M.Tosi reviewing and editing (supporting); GV Zuccotti reviewing and editing (supporting).

  4. Use of Large Language Models, AI and Machine Learning Tools: Not applicable.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Ferraro, S, Lucchi, S, Montanari, C, Magnani, L, Tosi, M, Biganzoli, D, et al.. Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs. Clin Chem Lab Med 2024;63:559–71. https://doi.org/10.1515/cclm-2024-0692.Search in Google Scholar PubMed

2. Moore, E, Mander, A, Ames, D, Carne, R, Sanders, K, Watters, D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012;24:541–56. https://doi.org/10.1017/s1041610211002511.Search in Google Scholar

3. Ferraro, S, Da Molin, S, Cereda, C, Zuccotti, G, Marcovina, S, Cesana, BM. Vitamin B12 deficiency and new recommendations by the National Institute for Health and Care Excellence: a challenging clinical and laboratory topic. Clin Chem 2025. https://doi.org/10.1093/clinchem/hvaf037 [Online ahead of print].Search in Google Scholar PubMed

4. Vitamin B12 deficiency in over 16s: diagnosis and management [C] Evidence review for diagnostic tests NICE guideline NG239. Evidence reviews underpinning recommendations 1.3.1 to 1.3.16 and recommendations for research in the NICE guideline March 2024: https://pubmed.ncbi.nlm.nih.gov/38713783/# [Accessed Dec 2024].Search in Google Scholar

5. Ferraro, S, Cereda, C, Zuccotti, G. Biochemical evidence of vitamin B12 deficiency: a crucial issue to address supplementation in pregnant women. Clin Chem Lab Med 2025;63:e153–5. https://doi.org/10.1515/cclm-2024-1405.Search in Google Scholar PubMed

6. Ferraro, S, Panteghini, M. Folate and vitamin B12 assays after recalibration to the WHO International Standard 03/178: making the interpretation as simple as possible, but not simpler. Clin Chem Lab Med 2019;57:1112–4. https://doi.org/10.1515/cclm-2019-0050.Search in Google Scholar PubMed

7. İspir, E, Serdar, MA, Ozgurtas, T, Gulbahar, O, Akın, KO, Yesildal, F, et al.. Comparison of four automated serum vitamin B12 assays. Clin Chem Lab Med 2015;53:1205–13. https://doi.org/10.1515/cclm-2014-0843.Search in Google Scholar PubMed

8. Braga, F, Frusciante, E, Ferraro, S, Panteghini, M. Trueness evaluation and verification of inter-assay agreement of serum folate measuring systems. Clin Chem Lab Med 2020;58:1697–705. https://doi.org/10.1515/cclm-2019-0928.Search in Google Scholar PubMed

9. van der Hagen, E, Weykamp, C, Sandberg, S, Stavelin, A, MacKenzie, F, Miller, W. Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. Clin Chem Lab Med 2021;59:117–25. https://doi.org/10.1515/cclm-2020-0736.Search in Google Scholar PubMed

10. van Rossum, HH, Holdenrieder, S, Ballieux, BEPB, Badrick, TC, Yun, YM, Zhang, C, et al.. Investigating the current harmonization status of tumor markers using global external quality assessment programs: a feasibility study. Clin Chem 2024;70:669–79. https://doi.org/10.1093/clinchem/hvae005.Search in Google Scholar PubMed

11. Jassam, N, Bancroft, T, Luvai, A, Mbagaya, W, Barth, JH. Vitamin B12 reference intervals on Beckman, Roche and Siemens analytical platforms. Ann Clin Biochem 2023;60:417–22. https://doi.org/10.1177/00045632231202211.Search in Google Scholar PubMed

12. Ozarda, Y, Ichihara, K, Barth, JH, Committee on Reference Intervals and Decision Limits (C-RIDL), International Federation for Clinical Chemistry and Laboratory Medicine. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med 2013;51:1027–40. https://doi.org/10.1515/cclm-2013-0249.Search in Google Scholar PubMed

13. Clinical and Laboratory Standards Institute (CLSI). EP09-A3 – measurement procedure comparison and bias estimation using patient samples; approved guideline, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.Search in Google Scholar

14. Goedhart, J, Rishniw, M. BA-plotteR – a web tool for generating Bland-Altman plots and constructing limits of agreement. Res Vet Sci 2021;137:281–6. https://doi.org/10.1016/j.rvsc.2021.05.017.Search in Google Scholar PubMed

15. Cesana, BM, Antonelli, P. Bland-Altman agreement method: to plot differences against means or differences against standard? An endless tale? Clin Chem Lab Med 2024;62:262–9. https://doi.org/10.1515/cclm-2023-0306.Search in Google Scholar PubMed

16. https://biologicalvariation.eu/search?query=Cobalamin Search in Google Scholar

17. Sandberg, S, Coskun, A, Carobene, A, Fernandez-Calle, P, Diaz-Garzon, J, Bartlett, WA, et al.. Analytical performance specifications based on biological variation data - considerations, strengths and limitations. Clin Chem Lab Med 2024;62:1483–9. https://doi.org/10.1515/cclm-2024-0108.Search in Google Scholar PubMed

18. Ferraro, S, Mozzi, R, Panteghini, M. Tracing a roadmap for vitamin B12 testing using the health technology assessment approach. Clin Chem Lab Med 2014;52:767–77. https://doi.org/10.1515/cclm-2013-0738.Search in Google Scholar PubMed

19. Carmel, R, Brar, S, Agrawal, A, Penha, PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017–8. https://doi.org/10.1093/clinchem/46.12.2017.Search in Google Scholar

20. Bowen, R, Benavides, R, Colón-Franco, JM, Katzman, BM, Muthukumar, A, Sadrzadeh, H, et al.. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem 2019;74:1–11. https://doi.org/10.1016/j.clinbiochem.2019.08.012.Search in Google Scholar PubMed

21. Pant, V, Tumbapo, A, Yadav, BK. Vitamin B12 immunoassay interference in a patient with multiple myeloma – troubleshooting in a two-step reagent kit based on enhanced chemiluminescence testing. EJIFCC 2018;29:152–5.Search in Google Scholar

22. Basu, S, Chaudhuri, S. Vitamin B(12) immunoassay on Roche elecsys 2010: effects of high excess concentration of serum vitamin B(12) in CKD patients on parenteral administration. Indian J Clin Biochem 2011;26:413–5. https://doi.org/10.1007/s12291-011-0129-z.Search in Google Scholar PubMed PubMed Central

23. Wolffenbuttel, BHR, Muller Kobold, AC, Sobczyńska-Malefora, A, Harrington, DJ. Macro-B12 masking B12 deficiency. BMJ Case Rep 2022;15:e247660. https://doi.org/10.1136/bcr-2021-247660.Search in Google Scholar PubMed PubMed Central

24. Oberley, MJ, Yang, DT. Laboratory testing for cobalamin deficiency in megaloblastic anemia. Am J Hematol 2013;88:522–6. https://doi.org/10.1002/ajh.23421.Search in Google Scholar PubMed

25. Carmel, R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011;94:348S–358S. https://doi.org/10.3945/ajcn.111.013441.Search in Google Scholar PubMed PubMed Central

26. Green, R. Unreliability of current assays to detect cobalamin deficiency: “nothing gold can stay”. Blood 2005;105:910–1. https://doi.org/10.1182/blood-2004-11-4293.Search in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0939).


Received: 2025-07-24
Accepted: 2025-08-12
Published Online: 2025-07-24
Published in Print: 2025-11-25

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Challenging the dogma: why reviewers should be allowed to use AI tools
  4. Multivariate approaches to improve the interpretation of laboratory data
  5. Review
  6. Interference of therapeutic monoclonal antibodies with electrophoresis and immunofixation of serum proteins: state of knowledge and systematic review
  7. Opinion Papers
  8. Urgent call to the European Commission to simplify and contextualize IVDR Article 5.5 for tailored and precision diagnostics
  9. The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference
  10. Supplementation of pyridoxal-5′-phosphate in aminotransferase reagents: a matter of patient safety
  11. HCV serology: an unfinished agenda
  12. From metabolic profiles to clinical interpretation: multivariate approaches to population-based and personalized reference intervals and reference change values
  13. Genetics and Molecular Diagnostics
  14. A multiplex allele specific PCR capillary electrophoresis (mASPCR-CE) assay for simultaneously analysis of SMN1/SMN2/NAIP copy number and SMN1 loss-of-function variants
  15. General Clinical Chemistry and Laboratory Medicine
  16. From assessment to action: experience from a quality improvement initiative integrating indicator evaluation and adverse event analysis in a clinical laboratory
  17. Evaluation of measurement uncertainty of 11 serum proteins measured by immunoturbidimetric methods according to ISO/TS 20914: a 1-year laboratory data analysis
  18. Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
  19. The current status of serum insulin measurements and the need for standardization
  20. Method comparison of plasma and CSF GFAP immunoassays across multiple platforms
  21. Cerebrospinal fluid leptin in Alzheimer’s disease: relationship to plasma levels and to cerebrospinal amyloid
  22. Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences
  23. An innovative immunoassay for accurate aldosterone quantification: overcoming low-level inaccuracy and renal dysfunction-associated interference
  24. Oral salt loading combined with postural stimulation tests for confirming and subtyping primary aldosteronism
  25. Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis
  26. Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels
  27. Reference Values and Biological Variations
  28. Establishment of region-, age- and sex-specific reference intervals for aldosterone and renin with sandwich chemiluminescence immunoassays
  29. Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
  30. Comparative analysis of population-based and personalized reference intervals for biochemical markers in peri-menopausal women: population from the PALM cohort study
  31. Hematology and Coagulation
  32. Evaluation of stability and potential interference on the α-thalassaemia early eluting peak and immunochromatographic strip test for α-thalassaemia --SEA carrier screening
  33. Cardiovascular Diseases
  34. Analytical and clinical evaluation of an automated high-sensitivity cardiac troponin I assay for whole blood
  35. Diabetes
  36. Method comparison of diabetes mellitus associated autoantibodies in serum specimens
  37. Letters to the Editor
  38. Permitting disclosed AI assistance in peer review: parity, confidentiality, and recognition
  39. Response to the editorial by Karl Lackner
  40. Hemolysis detection using the GEM 7000 at the point of care in a pediatric hospital setting: does it affect outcomes?
  41. Estimation of measurement uncertainty for free drug concentrations using ultrafiltration
  42. Cryoglobulin pre-analysis over the weekend
  43. Accelerating time from result to clinical action: impact of an automated critical results reporting system
  44. Recent decline in patient serum folate test levels using Roche Diagnostics Folate III assay
  45. Kidney stones consisting of 1-methyluric acid
  46. Congress Abstracts
  47. 7th EFLM Conference on Preanalytical Phase
  48. Association of Clinical Biochemists in Ireland Annual Conference
  49. Association of Clinical Biochemists in Ireland Annual Conference
  50. 17th Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine
Downloaded on 19.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0939/html
Scroll to top button